The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.
While providing chips for companies across the AI sector, Nvidia has also laid out plans in recent weeks to generate demand with new technologies of its own.
。夫子对此有专业解读
"published": self.published,
Source: Computational Materials Science, Volume 267
Continue reading...